# Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury

> **NCT01621113** · PHASE2 · COMPLETED · sponsor: **Kessler Foundation** · enrollment: 27 (actual)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Dalfampridine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01621113
- **Lead sponsor:** Kessler Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2017-10-09
- **Final completion:** 2017-10-16
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621113, "Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01621113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*